A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers
- Author
- KIESMAN, William F; ELZEIN, Elfatih; ZABLOCKI, Jeff
- Issue title
- Adenosine Receptors in Health and Disease
- Author (monograph)
- WILSON, Constance N (Editor)1 ; MUSTAFA, S. Jamal (Editor)2
[1] Endacea, Inc., P. O. Box 12076 (Mail), 2 Davis Drive (Courier), Research Triangle Park, NC 27709-2076, United States
[2] Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV 26505-9229, United States - Source
Handbook of experimental pharmacology. 2009, Vol 193, pp 25-58, 34 p ; ref : 4 p.1/2
- ISSN
- 0171-2004
- Scientific domain
- Pharmacology drugs
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Acutely decompensated heart failure Adentri Al adenosine receptor agonists Al adenosine receptor antagonists Allosteric enhancers Angina Anti-arrhythmic agents BG9928 CVT-3619 Capadenoson Cardiorenal syndrome Congestive heart failure Insulin sensitizing agents KW3902 Neuropathic pain SLV320 Selodenoson Tecadenoson Type II diabetes
- Keyword (fr)
- Activité biologique Agoniste antagoniste Allostérie Angine de poitrine Animal Antagoniste Antiarythmique Article synthèse Capadénoson Diabète de type 2 Douleur neuropathique Etude expérimentale Insuffisance cardiaque Insuline Névralgie Récepteur adénosinique A1 Récepteur adénosinique Régulation allostérique Sélodénoson Técadénoson Cardiopathie coronaire Endocrinopathie Hormone pancréatique Maladie métabolique Pathologie de l'appareil circulatoire Pathologie du système nerveux Trouble neurologique
- Keyword (en)
- Biological activity Agonist antagonist Allostery Angina pectoris Animal Antagonist Antiarrhythmic agent Review Capadenoson Type 2 diabetes Neuropathic pain Experimental study Heart failure Insulin Neuralgia A1 Adenosine receptor Adenosine receptor Allosteric regulation Selodenoson Tecadenoson Coronary heart disease Endocrinopathy Pancreatic hormone Metabolic diseases Cardiovascular disease Nervous system diseases Neurological disorder
- Keyword (es)
- Actividad biológica Agonista antagonista Alosterismo Angina pectoris Animal Antagonista Antiarrítmico Artículo síntesis Capadenosón Diabetes de tipo 2 Dolor neuropática Estudio experimental Insuficiencia cardíaca Insulina Neuralgia Receptor adenosínico A1 Receptor adenosínico Regulación alostérica Selodenosón Tecadenosón Cardiopatía coronaria Endocrinopatía Hormona pancreática Metabolismo patología Aparato circulatorio patología Sistema nervioso patología Trastorno neurológico
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17A Nervous system (semeiology, syndromes) / 002B17A08 Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Cardiology. Circulatory system Endocrinopathies Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21939492
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/978-3-540-89615-9_2 
https://dx.doi.org/10.1007/978-3-540-89615-9_2
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"58\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"KIESMAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"ELZEIN, Elfatih\";i:1;s:14:\"ZABLOCKI, Jeff\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"34\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"58\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"KIESMAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"ELZEIN, Elfatih\";i:1;s:14:\"ZABLOCKI, Jeff\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"34\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"58\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"KIESMAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"ELZEIN, Elfatih\";i:1;s:14:\"ZABLOCKI, Jeff\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"34\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"58\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"KIESMAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"ELZEIN, Elfatih\";i:1;s:14:\"ZABLOCKI, Jeff\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"34\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1007\/978-3-540-89615-9_2\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Handbook of experimental pharmacology\";s:9:\"\u0000*\u0000stitle\";s:21:\"Handb. exp. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"193\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"58\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-2004\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"KIESMAN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William F\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:15:\"ELZEIN, Elfatih\";i:1;s:14:\"ZABLOCKI, Jeff\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:41:\"Adenosine Receptors in Health and Disease\";s:8:\"\u0000*\u0000title\";s:69:\"A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"34\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
